Original Research
Published on 16 Nov 2022
Genetic dominance of transforming growth factor-β1 polymorphisms in chronic liver disease
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1058532
- 1,578 views
Type at least 3 characters
1,086 articles
Articles
Review
Published on 16 Nov 2022
Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1048758
- 4,640 views
- 7 citations
Original Research
Published on 16 Nov 2022
Cytokine/Chemokine assessment as a complementary diagnostic tool for inflammatory skin diseases
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1028435
- 2,418 views
- 5 citations
Review
Published on 14 Nov 2022
Platelet in thrombo-inflammation: Unraveling new therapeutic targets
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1039843
- 9,304 views
- 26 citations
Original Research
Published on 14 Nov 2022
Combinatorial depletions of G-protein coupled receptor kinases in immune cells identify pleiotropic and cell type-specific functions
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1039803
- 2,568 views
- 1 citation
Original Research
Published on 14 Nov 2022
Unbalanced networks and disturbed kinetics of serum soluble mediators associated with distinct disease outcomes in severe COVID-19 patients
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1004023
- 1,933 views
- 3 citations
Original Research
Published on 03 Nov 2022
Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1036200
- 4,416 views
- 8 citations
Mini Review
Published on 03 Nov 2022
The role of IL-38 in intestinal diseases - its potential as a therapeutic target
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1051787
- 2,471 views
- 5 citations
Original Research
Published on 31 Oct 2022
Potent anti-inflammatory activity of the lectin-like domain of TNF in joints
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1049368
- 1,612 views
- 2 citations
Original Research
Published on 28 Oct 2022
Microglia shield the murine brain from damage mediated by the cytokines IL-6 and IFN-α
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1036799
- 5,247 views
- 8 citations
Original Research
Published on 28 Oct 2022
Modulation of immune cell function, IDO expression and kynurenine production by the quorum sensor 2-heptyl-3-hydroxy-4-quinolone (PQS)
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1001956
- 2,848 views
- 3 citations
Original Research
Published on 27 Oct 2022
Cytokine-primed umbilical cord mesenchymal stem cells enhanced therapeutic effects of extracellular vesicles on osteoarthritic chondrocytes
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1041592
- 3,346 views
- 8 citations
Review
Published on 27 Oct 2022
The role of platelet mediated thromboinflammation in acute liver injury
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1037645
- 3,689 views
- 15 citations
Original Research
Published on 26 Oct 2022
Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.971659
- 2,768 views
- 5 citations
Review
Published on 21 Oct 2022
Role of metabolic reprogramming in pro-inflammatory cytokine secretion from LPS or silica-activated macrophages
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.936167
- 9,419 views
- 48 citations
Systematic Review
Published on 21 Oct 2022
Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.1046352
- 3,531 views
- 4 citations